SCHEMBL18463239

SCHEMBL18463239

Brc1ccc(Nc2nc3cc(Br)ccc3[nH]2)c(Br)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.41
NPC1 O15118 4/20 0.38
RAB9A P51151 4/20 0.38
MAPT P10636 3/20 0.38
LMNA P02545 2/20 0.38
TP53 P04637 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
MEN1 O00255 4/20 0.37
KMT2A Q03164 4/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
ALDH1A1 P00352 3/20 0.36
HPGD P15428 2/20 0.36
KDM4E B2RXH2 1/20 0.36
TAAR1 Q96RJ0 1/20 0.36
LCK P06239 2/20 0.35
ALOX15 P16050 1/20 0.35
CSNK1D P48730 1/20 0.34
RAF1 P04049 1/20 0.34
BRAF P15056 1/20 0.34
IDH2 P48735 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18463370 0.88 GAA (0.56) GAANPC1RAB9AMAPTLMNA
SCHEMBL24996856 0.80 GPR84 (0.42) GAANPC1RAB9AMAPTLMNA
SCHEMBL30166993 0.80 GPR84 (0.42) GAANPC1RAB9AMAPTLMNA
SCHEMBL1333872 0.78 MEN1 (0.51) GAANPC1RAB9AMAPTLMNA
SCHEMBL28877884 0.77 MAOA (0.42) NPC1RAB9AMAPTLMNAMEN1
SCHEMBL29967151 0.77 MAOA (0.42) NPC1RAB9AMAPTLMNAMEN1
SCHEMBL1748009 0.74 CSNK1D (0.47) MAPTTP53KDM4ECSNK1DIDH2
SCHEMBL18463385 0.74 RAB9A (0.56) GAANPC1RAB9AMAPTLMNA
SCHEMBL31451819 0.74 RAB9A (0.56) GAANPC1RAB9AMAPTLMNA
SCHEMBL4812260 0.74 TRPV1 (0.46) GAANPC1RAB9AMAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3328860-B2 PROCESS FOR THE PREPARATION OF BENZIMIDAZO[1,2-A]BENZIMIDAZOLES UDC IRELAND LTD (IE) 2022-11-02 EP disclosed
EP-3328860-B1 PROCESS FOR THE PREPARATION OF BENZIMIDAZO[1,2-A]BENZIMIDAZOLES UDC IRELAND LTD (IE) 2020-03-04 EP disclosed
EP-3328860-B1 PROCESS FOR THE PREPARATION OF BENZIMIDAZO[1,2-A]BENZIMIDAZOLES UDC IRELAND LTD (IE) 2020-03-04 EP disclosed
US-10570136-B2 Process for the preparation of benzimidazo[1,2-a] benzimidazoles UDC IRELAND LIMITED (IE) 2020-02-25 US disclosed
US-10570136-B2 Process for the preparation of benzimidazo[1,2-a] benzimidazoles UDC IRELAND LIMITED (IE) 2020-02-25 US disclosed
US-20180170936-A1 PROCESS FOR THE PREPARATION OF BENZIMIDAZO[1,2-A] BENZIMIDAZOLES UDC IRELAND LIMITED (IE) 2018-06-21 US disclosed
US-20180170936-A1 PROCESS FOR THE PREPARATION OF BENZIMIDAZO[1,2-A] BENZIMIDAZOLES UDC IRELAND LIMITED (IE) 2018-06-21 US disclosed
WO-2017017096-A1 PROCESS FOR THE PREPARATION OF BENZIMIDAZO[1,2-A]BENZIMIDAZOLES UDC IRELAND LIMITED (IE) 2017-02-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10570136-B2 Process for the preparation of benzimidazo[1,2-a] benzimidazoles CYP3A4, CYP2C19, CYP1B1 GAA 174/4885NPC1 2735/4885RAB9A 2804/4885
US-20180170936-A1 PROCESS FOR THE PREPARATION OF BENZIMIDAZO[1,2-A] BENZIMIDAZOLES CYP3A4, CYP2C19, CYP1B1 GAA 174/4885NPC1 2735/4885RAB9A 2804/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.